Skip to content

Ocular Therapeutix OCUL Other Non-Current Liabilities

Other Non-Current Liabilities at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$2.13B+27.0%
Bausch + Lomb logo
Bausch + LombBLCO
$458M-1.9%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$16.08M
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$42M+145%
PBH
Prestige Consumer HealthcarePBH
$5.58M+3.5%
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
$431K+19.7%

Other financials

Income statement

See full
Revenue$10.8M+0.8%
Gross profit$9.5M+0.2%
Operating income-$93.3M-46.0%
Net income-$88.6M-38.3%
EPS (diluted)-$0.40-5.3%

Balance sheet

See full
Cash & equivalents$666.7M+90.7%
Total debt$79.5M+4.2%
Total equity$581.6M+119%
Total assets$732.5M+80.5%

Cash flow

See full
Operating cash flow-$66.0M-47.7%
CapEx$4.7M+141%
Free cash flow-$70.7M-51.6%

Valuation

See full
Market cap$2.21B+58.2%
Enterprise value$1.63B+40.8%
P/S42.6×+19.1×

Profitability

See full
Gross margin87.2%-3.4pp
Operating margin-575.4%+1,233pp
Net margin-558.2%+1,493pp
FCF margin-463%+2,860pp

Returns & leverage

See full
Return on equity-68.6%+17.0pp
Debt / equity0.1×-0.2×
Current ratio14.8×+4.6×

Where this comes from

Reported directly by Ocular Therapeutix in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.

The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ocular Therapeutix's other non-current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ocular Therapeutix's other non-current liabilities?
Ocular Therapeutix (OCUL) reported other non-current liabilities of $909K in Q1 2026.
How has Ocular Therapeutix's other non-current liabilities changed year-over-year?
Ocular Therapeutix's other non-current liabilities increased by 531.3% year-over-year, from $144K to $909K.
What is the long-term trend for Ocular Therapeutix's other non-current liabilities?
Over 3 years (2022 to 2025), Ocular Therapeutix's other non-current liabilities has grown at a 112.1% compound annual growth rate (CAGR), from $93K to $887K.
What does other non-current liabilities mean?
Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.